Workgroup Mandate: Support Diversity, Equality, and Inclusion in Clinical Research
Purpose: To create and provide educational and support tools for clinical research sites with the purpose of better engaging diverse communities in the areas they serve.
Description: Leaders across the research industry and advocacy will work to research, design and develop the following:
- Tools to assist research sites to better work within diverse communities;
- Best practices guidance document and checklist;
- Metrics that will help measure progress and objectively evaluate outcomes;
- Cultural Tenets: exploration of broad range of tenets, including but not limited to, race, ethnicity, gender, sexual orientation, socio-economic, geographical, religious preferences.
Objective: Educate diverse communities on clinical research to build trust with our communities on the safety and efficacy around clinical research.
Specifications: Leaders from across the research industry and advocacy will meet quarterly to discuss project needs, ideas and scope of work. An online platform will be used to share information, communicate between meetings and serve as a central hub to formulate deliverables. Workgroup participants are encouraged to share information with peers and organizations to solicit feedback and suggestions for the workgroup.
Workgroup Co-Chairs: Responsibilities include helping to set the agenda, lead the quarterly workgroup calls, and helping establish and drive the output for the group between calls.
Deliverables:
- Develop guidelines and/or SOP’s on various cultural barriers and practical ways to overcome those barriers and engage each group in a culturally-thoughtful way.
- Multimedia presentation on “What is Cultural Competency?”
- Build out the Diversity Module as part of the STARR Site Certification, starting by defining measurable objectives for site training.
Deliverables Created:
Links:
- FDA’s Guidance on Diversity in Clinical Trials
- NIH Diversity & Inclusion in Clinical Trials
- Fierce Biotech article on diversity: “Here’s what the committee thinks equitable research looks like: a clinical trial population that matches the demographics of the disease being studied.”
Diversity Requirements Imminent: Age, Sex, Race — Are You Prepared?
(From the July STARR Newsletter)
The FDA’s draft guidance, “Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials” was issued in April of 2022 to provide guidance and recommendations to sponsors for developing diversity plans to enroll adequate numbers of participants in clinical trials from underrepresented racial and ethnic populations in the US.
- Your database needs to include age, sex, and race.
- Your community demographics information should be accurate, current, and supported by a source.
- Your diversity engagement plan should include concrete plans and action-items.
- You may need to be prepared to defend your diversity program.
- FDA Draft Guidance
- News article: Diversity Requirements
- Congressional Food and Drug Omnibus Reform Act (FDORA) article
- Summary and Analysis of FDORA
————————————————————————————————–
NOTE: This is an active workgroup and this page is updated regularly.
Letitia Griffin (Co-chair)
CNS Healthcare
Shishuka Malhotra (Co-Chair)
Neuro-Behavioral Clinical Research
Temitope Keyes (Co-Chair)
Adaptive Clinical Systems
Jim Bentley
Neuro-Behavioral Clinical Research
Inez Ruiz-White
Otsuka
Zach Mitchell
iResearch Atlanta
Kimberly Wolf
Synergy San Diego
Patrick Ezeh
Biogen
Nadine McLeod
Biogen
Poorvi Chablani
Biogen
Leslie Franceschi
Franceschi Clinical Research Consulting
Sarah Titus
Sage
Jacob Silberstein
Sage
Taylor McCleod
Sage
Van Johnson
Benchmark Research
Bruce Trimble
Pillar Clinical Research
Irena Webster
Forma Therapeutics
Luke Kramer
ERG
Chuck Wilcox
Praxis Research Consulting
Tabatha Cirgenski-Ruiz
Segal Trials
Amy Schemer
CNS Healthcare
Kimberly King
DBSA
Matthew Shapiro
NAMI NY
Katerina Lehky
The STARR Coalition
Erica Moore
The STARR Coalition